These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22862969)

  • 1. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
    Kashimoto K; Komatsu S; Ichikawa D; Arita T; Konishi H; Nagata H; Takeshita H; Nishimura Y; Hirajima S; Kawaguchi T; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Cancer Sci; 2012 Nov; 103(11):2021-6. PubMed ID: 22862969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
    Kawaguchi T; Komatsu S; Ichikawa D; Hirajima S; Nishimura Y; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Tumour Biol; 2017 Jun; 39(6):1010428317700409. PubMed ID: 28618928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of TRIM44 Inhibits the Proliferation and Invasion in Prostate Cancer Cells.
    Tan Y; Yao H; Hu J; Liu L
    Oncol Res; 2017 Sep; 25(8):1253-1259. PubMed ID: 28160462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy.
    Ong CA; Shannon NB; Ross-Innes CS; O'Donovan M; Rueda OM; Hu DE; Kettunen MI; Walker CE; Noorani A; Hardwick RH; Caldas C; Brindle K; Fitzgerald RC
    J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma.
    Nishimura Y; Komatsu S; Ichikawa D; Nagata H; Hirajima S; Takeshita H; Kawaguchi T; Arita T; Konishi H; Kashimoto K; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2013 Apr; 108(6):1324-31. PubMed ID: 23422756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma.
    Kobayashi H; Komatsu S; Ichikawa D; Kawaguchi T; Hirajima S; Miyamae M; Okajima W; Ohashi T; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Oncotarget; 2015 Nov; 6(34):36615-24. PubMed ID: 26472028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TRIM44 and its correlation with TLR4 in laryngeal squamous cell carcinoma.
    Bai J; Liu X; Zhang S; Dang S; Zhang Y; Zhang G
    Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):56-61. PubMed ID: 36227676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor.
    Yamada Y; Takayama KI; Fujimura T; Ashikari D; Obinata D; Takahashi S; Ikeda K; Kakutani S; Urano T; Fukuhara H; Homma Y; Inoue S
    Cancer Sci; 2017 Jan; 108(1):32-41. PubMed ID: 27754579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
    Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
    Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripartite Motif-Containing 44 is Involved in the Tumorigenesis of Laryngeal Squamous Cell Carcinoma, and its Expression is Downregulated by Nuciferine.
    Li QH; Sui LP; Zhao YH; Chen BG; Li J; Ma ZH; Hu ZH; Tang YL; Guo YX
    Tohoku J Exp Med; 2021 May; 254(1):17-23. PubMed ID: 34011804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Novel Target of Colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion via Activation of CXCR4/NF-κB Signaling.
    Kou T; Sha D; Wang F; He T; He X
    Cell Biochem Biophys; 2021 Mar; 79(1):113-121. PubMed ID: 33151473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
    Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.
    Luo Q; Lin H; Ye X; Huang J; Lu S; Xu L
    Int J Clin Oncol; 2015 Jun; 20(3):508-17. PubMed ID: 25345539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma.
    Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Carcinogenesis; 2018 Feb; 39(2):263-271. PubMed ID: 29228320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
    Zhou Z; Liu Y; Ma M; Chang L
    Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.
    Komatsu S; Ichikawa D; Hirajima S; Nagata H; Nishimura Y; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Imoto I; Inazawa J; Otsuji E
    Br J Cancer; 2015 Jan; 112(2):357-64. PubMed ID: 25321194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
    Li P; Yin H; Meng F; Liu S; Liu H; Ma R
    Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis.
    Xiao G; Yang Q; Bao Z; Mao H; Zhang Y; Lin S
    BMC Cancer; 2020 Jun; 20(1):525. PubMed ID: 32503466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.